BIT 5.33% 7.1¢ biotron limited

$10 Billion Deal, page-141

  1. 15,757 Posts.
    lightbulb Created with Sketch. 668
    "Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial "

    Can someone explain how they came to this conclusion in a short time frame after treatment based on 27 patients with half on placebo. The variability of data on such a small patient population looking at immune system ages and neurocognitive disorder is going to give you non conclusive data imo. Longer term data on over 300 patients in a phase 2b study can only give any significant results. IMO the reported results are a beat up to get the 6c options exercised.


    "These include an immune system ages more quickly, and there are other problems such as HIV-associated neurocognitive disorder (also known as AIDS-related dementia).
    Last edited by malmanu: 13/11/18
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.004(5.33%)
Mkt cap ! $49.83M
Open High Low Value Volume
7.2¢ 7.4¢ 7.1¢ $44.06K 612.6K

Buyers (Bids)

No. Vol. Price($)
4 219752 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 243308 2
View Market Depth
Last trade - 16.10pm 28/01/2022 (20 minute delay) ?
(live)
Last
7.3¢
  Change
-0.004 ( 0.82 %)
Open High Low Volume
7.2¢ 7.3¢ 7.1¢ 347177
Last updated 15.57pm 28/01/2022 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.